Rilpivirine | Licensing, EU CTD Dossiers, Formulation Listed Suppliers | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Clinical Trials
- Clinical Trials
Drugs in Dev.
News
Blog
Market Place
Login

Rilpivirine
Listed Dossiers

PharmaCompass Sponsored Ads

Contact Supplier

China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

pharmacompass-2-m-2026-04-20

Rilpivirine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 4 USDMF, 1 KDMF, 7 NDC API, 8 Listed Suppliers

15 API Suppliers
4 USDMF
1 KDMF
7 NDC API
8 Listed Suppliers

DEVELOPMENTS

56 Drugs in Development

56 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

38 FDF Dossiers, 4 FDA Orange Book, 20 Europe, 2 Canada, 4 Australia, 4 South Africa, 4 Listed Dossiers

38 FDF Dossiers
4 FDA Orange Book
20 Europe
2 Canada
4 Australia
4 South Africa
4 Listed Dossiers

DIGITAL CONTENT

70 News #PharmaBuzz

70 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 39 Annual Reports

4 US Medicaid Prescriptions
2 Regulatory FDF Prices
39 Annual Reports

MARKET PLACE

3 APIs, 2 FDF Dossiers

3 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 US Patents, 2 US Exclusivities, 24 Health Canada Patents

16 US Patents
2 US Exclusivities
24 Health Canada Patents

REF. STANDARDS & IMPURITIES

9 Others

9 Others

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4Pharmathen SA

filter Active Ingredients Reset all filters

4 All

01 4Cabotegravir; Rilpivirine

filter Dosage Reset all filters

4 All

01 4Long Acting Injectable

filter Dosage Strength Reset all filters

4 All

01 1400MG/ML; 600MG/ML

02 1400MG; 600MG

03 1600MG/ML; 900MG/ML

04 1600MG; 900MG

filter Country Reset all filters

4 All

01 4Greece

Minakem Rilpivirine

List of Suppliers

Product Main Page

01

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : USA

Registration Country : Greece

Cabotegravir; Rilpivirine

Brand Name :

Dosage Form : Long Acting Injectable

Dosage Strength : 400MG; 600MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : USA

Registration Country : Greece

Product Web Link

Digital Content

01

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info : USA

Cabotegravir; Rilpivirine

Dosage : Long Acting Injectable

Dosage Strength : 400MG; 600MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Greece

Product Web Link

Digital Content

02

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : USA

Registration Country : Greece

Cabotegravir; Rilpivirine

Brand Name :

Dosage Form : Long Acting Injectable

Dosage Strength : 400MG/ML; 600MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : USA

Registration Country : Greece

Product Web Link

Digital Content

02

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info : USA

Cabotegravir; Rilpivirine

Dosage : Long Acting Injectable

Dosage Strength : 400MG/ML; 600MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : Greece

Product Web Link

Digital Content

03

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : USA

Registration Country : Greece

Cabotegravir; Rilpivirine

Brand Name :

Dosage Form : Long Acting Injectable

Dosage Strength : 600MG; 900MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : USA

Registration Country : Greece

Product Web Link

Digital Content

03

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info : USA

Cabotegravir; Rilpivirine

Dosage : Long Acting Injectable

Dosage Strength : 600MG; 900MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Greece

Product Web Link

Digital Content

04

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : USA

Registration Country : Greece

Cabotegravir; Rilpivirine

Brand Name :

Dosage Form : Long Acting Injectable

Dosage Strength : 600MG/ML; 900MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : USA

Registration Country : Greece

Product Web Link

Digital Content

04

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Pharmathen SA

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging :

Regulatory Info : USA

Cabotegravir; Rilpivirine

Dosage : Long Acting Injectable

Dosage Strength : 600MG/ML; 900MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : Greece

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.